Metropolis Healthcare Limited — Board Meeting, 13-05-2025: Outcome of Board Meeting

Metropolis Healthcare has announced a board meeting on May 13, 2025, approving the audited consolidated financial results for the quarter and financial year ended March 31, 2025. The company posted consolidated revenue of Rs. 1,346.3 Cr and PAT of Rs. 145.5 Cr, showing solid growth. Leadership updates include re-appointing Ms. Ameera Shah as Chairperson & Whole-time Director for five years from March 2026 and appointing Mr. Surendran Chemmenkotil as Managing Director from June 2025. Mr. Rehan Khan joins as Independent Director. New ESOP and RSU plans were approved, subject to shareholder nod. Core Diagnostic is now a wholly owned subsidiary, underpinning Metropolis’s expansion drive.